10x Genomics (TXG) Misses Q4 EPS by 9c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
10X Genomics (TXG) PT Lowered to $20 at Citi
February 13, 2025 6:40 AM ESTCiti analyst Patrick Donnelly lowered the price target on 10X Genomics (NASDAQ: TXG) to $20.00 (from $23.00) while maintaining a Buy rating.
The analyst comments "After pre-announcing last month, TXG reported official 4Q revenue of $165mn, above FactSet consensus of ~$160mn and the... More
